Oireachtas Joint and Select Committees
Wednesday, 8 November 2017
Joint Oireachtas Committee on Health
Evaluating Orphan Drugs: Discussion (Resumed)
9:00 am
Mr. John Hennessy:
As a matter of course, generally the HSE would appeal to the companies to lodge their applications with all their information, including their final best-price offer. It is not helpful for companies to be coming in at a high price and then being prepared to come down subsequent to decisions being taken. All that achieves is delaying the process and keeping a protracted process going. Our preference would be to conduct a clean process and have the absolute bottom-line price on the table from the word go.
No comments